{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:18:09Z","timestamp":1792840689766,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Cocaine and cocaine mixed with levamisole are increasingly used in the UK and result in significant direct nasal damage in addition to promoting vasculitis. Our aims were as follows: (1) to identify the main symptoms and presentation of cocaine-induced vasculitis; (2) to provide evidence regarding the best practice for the investigation and diagnosis of cocaine-induced vasculitis; and (3) to analyse the clinical outcomes of patients in order to understand the optimal management for the condition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective case series analysis of patients presenting with cocaine-induced midline destructive lesions or vasculitis compatible with granulomatosis with polyangiitis (GPA) from two large tertiary vasculitis clinics between 2016 and 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-two patients (29 Birmingham, 13 London) with cocaine-induced midline lesions or systemic disease were identified. The median age was 41\u2009years (range 23\u201366\u2009years). Current cocaine use was common, and 20 of 23 samples provided were positive when routine urine toxicology was performed; 9 patients who denied ever using cocaine were identified as using cocaine based on urine toxicology analysis, and 11 who stated they were ex-users still tested positive. There was a high incidence of septal perforation (75%) and oronasal fistula (15%). Systemic manifestations were less common (27%), and only one patient had acute kidney injury. Fifty-six per cent of our patients were PR3-ANCA positive, with none testing positive for MPO-ANCA. Symptom remission required cocaine discontinuation even when immunosuppression was administered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with destructive nasal lesions, especially young patients, should have urine toxicology performed for cocaine before diagnosing GPA and considering immunosuppressive therapy. The ANCA pattern is not specific for cocaine-induced midline destructive lesions. Treatment should be focused on cocaine cessation and conservative management in the first instance in the absence of organ-threatening disease.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rap\/rkad027","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:52:11Z","timestamp":1680569531000},"source":"Crossref","is-referenced-by-count":22,"title":["Cocaine-induced granulomatosis with polyangiitis\u2014an under-recognized condition"],"prefix":"10.1093","volume":"7","author":[{"given":"Charn","family":"Gill","sequence":"first","affiliation":[{"name":"Department of ENT Surgery, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sturman","sequence":"additional","affiliation":[{"name":"Renal Unit, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Ozbek","sequence":"additional","affiliation":[{"name":"Department of ENT surgery, Royal National ENT Hospital, University College London Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R","family":"Henderson","sequence":"additional","affiliation":[{"name":"UCL Department of Renal Medicine, , Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"Burns","sequence":"additional","affiliation":[{"name":"Renal Unit, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hamour","sequence":"additional","affiliation":[{"name":"Renal Unit, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J","family":"Pepper","sequence":"additional","affiliation":[{"name":"UCL Department of Renal Medicine, , Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"McClelland","sequence":"additional","affiliation":[{"name":"Department of ENT Surgery, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-7500","authenticated-orcid":false,"given":"Dimitrios","family":"Chanouzas","sequence":"additional","affiliation":[{"name":"Department of ENT Surgery, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"},{"name":"Institute Applied Health Research, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gane","sequence":"additional","affiliation":[{"name":"Department of ENT surgery, Royal National ENT Hospital, University College London Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"Salama","sequence":"additional","affiliation":[{"name":"UCL Department of Renal Medicine, , Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-9234","authenticated-orcid":false,"given":"Lorraine","family":"Harper","sequence":"additional","affiliation":[{"name":"Department of ENT Surgery, University Hospitals Birmingham NHS Foundation Trust , Birmingham, UK"},{"name":"Institute Applied Health Research, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"2023040400520636500_","year":"2021"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00005792-200111000-00005","article-title":"Cocaine-induced midline destructive lesions","volume":"80","author":"Trimarchi","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/20009666.2018.1536242","article-title":"Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis","volume":"8","author":"Jin","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/BOR.0b013e3282f1dcf2","article-title":"Vasculitis mimics","volume":"20","author":"Molloy","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13000-015-0279-z","article-title":"Pathologic manifestations of levamisole-adulterated cocaine exposure","volume":"10","author":"Nolan","year":"2015","journal-title":"Diagn Pathol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/014556139607500913","article-title":"Nasal septal necrosis mimicking Wegener\u2019s granulomatosis in a cocaine abuser","volume":"75","author":"Armstrong","year":"1996","journal-title":"Ear Nose Throat J"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00296-019-04410-9","article-title":"Cocaine-induced ANCA-associated renal disease: a case-based review","volume":"39","author":"L\u00f6tscher","year":"2019","journal-title":"Rheumatol Int"},{"key":"2023040400520636500_","first-page":"638","article-title":"Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity","volume":"56","author":"Lood","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.20479","article-title":"Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis","volume":"50","author":"Wiesner","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"e89780","DOI":"10.1172\/jci.insight.89780","article-title":"A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity","volume":"2","author":"Carmona-Rivera","year":"2017","journal-title":"JCI Insight"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"281","DOI":"10.14639\/0392-100X-1586","article-title":"Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis","volume":"37","author":"Trimarchi","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"434717","DOI":"10.1155\/2014\/434717","article-title":"Levamisole-contaminated cocaine: an emergent cause of vasculitis and skin necrosis","volume":"2014","author":"Souied","year":"2014","journal-title":"Case Rep Med"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"e547023","DOI":"10.1155\/2015\/547023","article-title":"Systemic levamisole-induced vasculitis in a cocaine user without cutaneous findings: a consideration in diagnosis","volume":"2015","author":"Baptiste","year":"2015","journal-title":"Case Rep Med"},{"key":"2023040400520636500_","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225913","article-title":"Unusual case of levamisole-induced dual-positive ANCA vasculitis and crescentic glomerulonephritis","author":"Kumar","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.prp.2016.03.008","article-title":"Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis","volume":"212","author":"Moinuddin","year":"2016","journal-title":"Pathol Res Pract"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2017.11.011","article-title":"Cocaine and ANCA associated vasculitis-like syndromes \u2013 a case series","volume":"17","author":"Subesinghe","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-022-02885-9","article-title":"Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort study","volume":"24","author":"Thayakaran","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","article-title":"Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease","volume":"6","author":"McGrath","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/RHU.0000000000000910","article-title":"Atypical chronic inflammatory ANCA-positive deforming arthritis after cocaine-levamisole exposure","volume":"26","author":"Emil","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/dta.1954","article-title":"Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project","volume":"9","author":"Brunt","year":"2017","journal-title":"Drug Test Anal"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10067-011-1805-3","article-title":"A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine","volume":"30","author":"Gross","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2023040400520636500_","first-page":"e17192","article-title":"Cocaine and levamisole induced vasculitis","volume":"13","author":"Gill","year":"2021","journal-title":"Cureus"},{"key":"2023040400520636500_","first-page":"e5198","article-title":"Levamisole-induced vasculitis in a hepatitis C patient: a general medicine ward perspective on diagnosis and management","volume":"11","author":"Latif","year":"2019","journal-title":"Cureus"},{"key":"2023040400520636500_","first-page":"109","article-title":"P-ANCA positive cocaine associated vasculitis: a case report","volume":"32","author":"Pham","year":"2005","journal-title":"J Cutan Pathol"},{"key":"2023040400520636500_","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/ADM.0000000000000290","article-title":"Unexpected complication of cocaine-associated anti-neutrophil cytoplasmic antibody vasculitis related to persistent in-hospital cocaine use","volume":"11","author":"Olives","year":"2017","journal-title":"J Addict Med"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/7\/1\/rkad027\/49727011\/rkad027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/7\/1\/rkad027\/49727011\/rkad027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T04:59:23Z","timestamp":1702184363000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkad027\/7099664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkad027","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,12,30]]},"article-number":"rkad027"}}